Oruka Therapeutics, Inc. (ORKA) — Multiple Insider Sales — Jul 1, 2026

5 insiders at Oruka Therapeutics, Inc. (ORKA) sold shares totaling approximately $1.50B.

• Peter Evan Harwin (Director, 10% Owner) — 3,553,410 shares at $84.43/share ($300.01M) • Healthcare Fund Ii L.P. Fairmount (Director, 10% Owner) — 3,553,410 shares at $84.43/share ($300.01M) • Funds Management Llc Fairmount (Director, 10% Owner) — 3,553,410 shares at $84.43/share ($300.01M) • Tomas Kiselak (Director, 10% Owner) — 3,553,410 shares at $84.43/share ($300.01M) • Healthcare Co-Invest Iii L.P. Fairmount (Director, 10% Owner) — 3,553,410 shares at $84.43/share ($300.01M)

While insider sales can occur for many reasons — including diversification, tax planning, or personal liquidity needs — clustered selling by multiple insiders may warrant attention.